NL
RMD icon

NVWM LLC’s ResMed RMD Stock Holding History

NVWM LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36K Buy
7
+1
+17% +$207 ﹤0.01% 571
2026
Q1 		$1.35K Hold
6
– – ﹤0.01% 531
2025
Q4 		$1.45K Buy
6
+1
+20% +$256 ﹤0.01% 526
2025
Q3 		$1.37K Hold
5
– – ﹤0.01% 487
2025
Q2 		$1.29K Sell
5
-1
-17% -$239 ﹤0.01% 490
2025
Q1 		$1.34K Buy
6
+1
+20% +$233 ﹤0.01% 446
2024
Q4 		$1.14K Hold
5
– – ﹤0.01% 449
2024
Q3 		$1.22K Buy
5
+1
+25% +$223 ﹤0.01% 439
2024
Q2 		$766 Buy
+4
New +$812 ﹤0.01% 476

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NVWM LLC's RMD Position: Q2 2026 in Review

NVWM LLC increased its ResMed (RMD) stake by 17% in Q2 2026, buying an estimated $207 and bringing the position to 7 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

NVWM LLC first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.45K in Q4 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • NVWM LLC held 7 shares of ResMed worth $1.36K as of Q2 2026.
  • NVWM LLC bought 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #571 holding.
  • NVWM LLC first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • NVWM LLC's ResMed position peaked at $1.45K in Q4 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.